TITLE

VEGFR1 and VEGFR2 Involvement in Extracellular Galectin-1- and Galectin-3-Induced Angiogenesis

AUTHOR(S)
D'Haene, Nicky; Sauvage, Sébastien; Maris, Calliope; Adanja, Ivan; Le Mercier, Marie; Decaestecker, Christine; Baum, Linda; Salmon, Isabelle
PUB. DATE
June 2013
SOURCE
PLoS ONE;Jun2013, Vol. 8 Issue 6, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Aim: Accumulating evidence suggests that extracellular galectin-1 and galectin-3 promote angiogenesis. Increased expression of galectin-1 and/or galectin-3 has been reported to be associated with tumour progression. Thus, it is critical to identify their influence on angiogenesis. Methods: We examined the individual and combined effects of galectin-1 and galectin-3 on endothelial cell (EC) growth and tube formation using two EC lines, EA.hy926 and HUVEC. The activation of vascular endothelial growth factor receptors (VEGFR1 and VEGFR2) was determined by ELISA and Western blots. We evaluated the VEGFR1 and VEGFR2 levels in endosomes by proximity ligation assay. Results: We observed different responses to exogenous galectins depending on the EC line. An enhanced effect on EA.hy926 cell growth and tube formation was observed when both galectins were added together. Focusing on this enhanced effect, we observed that together galectins induced the phosphorylation of both VEGFR1 and VEGFR2, whereas galectin-1 and −3 alone induced VEGFR2 phosphorylation only. In the same way, the addition of a blocking VEGFR1 antibody completely abolished the increase in tube formation induced by the combined addition of both galectins. In contrast, the addition of a blocking VEGFR2 antibody only partially inhibited this effect. Finally, the addition of both galectins induced a decrease in the VEGFR1 and VEGFR2 endocytic pools, with a significantly enhanced effect on the VEGFR1 endocytic pool. These results suggest that the combined action of galectin-1 and galectin-3 has an enhanced effect on angiogenesis via VEGFR1 activation, which could be related to a decrease in receptor endocytosis.
ACCESSION #
88909904

 

Related Articles

  • Galectin-1 induces vascular permeability through the neuropilin-1/vascular endothelial growth factor receptor-1 complex. Wu, Ming-Heng; Ying, Nien-Wen; Hong, Tse-Ming; Chiang, Wei-Fan; Lin, Yueh-Te; Chen, Yuh-Ling // Angiogenesis;Oct2014, Vol. 17 Issue 4, p839 

    Galectin-1 (Gal-1) is a β-galactoside-binding lectin that regulates endothelial cell migration, proliferation, and adhesion. However, the effect of Gal-1 on vascular permeability and the underlying mechanisms are unclear. We found that high Gal-1 expression was associated with elevated tumor...

  • Release of endothelial cell associated VEGFR2 during TGF-β modulated angiogenesis in vitro. Jarad, M.; Kuczynski, E. A.; Morrison, J.; Viloria-Petit, A. M.; Coomber, B. L. // BMC Cell Biology;1/23/2017, Vol. 18, p1 

    Background: Sprouting angiogenesis requires vascular endothelial proliferation, migration and morphogenesis. The process is regulated by soluble factors, principally vascular endothelial growth factor (VEGF), and via bidirectional signaling through the Jagged/Notch system, leading to assignment...

  • Involvement of αβ integrin in gremlin-induced angiogenesis. Ravelli, Cosetta; Mitola, Stefania; Corsini, Michela; Presta, Marco // Angiogenesis;Jan2013, Vol. 16 Issue 1, p235 

    αβ integrin modulates pro-angiogenic endothelial cell (EC) responses following vascular endothelial growth factor receptor-2 (VEGFR2) engagement. The bone morphogenic protein antagonist gremlin is a novel non-canonical VEGFR2 ligand that promotes the acquisition of a pro-angiogenic...

  • ADAMTS13 and its variants promote angiogenesis via upregulation of VEGF and VEGFR2. Lee, Manfai; Keener, Justin; Xiao, Juan; Long Zheng, X.; Rodgers, George // Cellular & Molecular Life Sciences;Jan2015, Vol. 72 Issue 2, p349 

    Severe plasma ADAMTS13 deficiency results in the clinical disorder thrombotic thrombocytopenic purpura. However, other potential pathophysiological roles of ADAMTS13 in endothelial cell biology remain unexplored. The goals of this study were to understand the angiogenic pathways ADAMTS13...

  • Ferula gummosa Boiss flower and leaf extracts inhibit angiogenesis in vitro. Mirzaaghaei, S.; Akrami, H.; Asadi, M. H.; Mahdiuni, H. // Indian Journal of Cancer;Oct-Dec2014, Vol. 51 Issue 4, p615 

    Background: Angiogenesis is a vital process in development as well as in tumor metastasis. Therefore, inhibition of tumor angiogenesis may be an approach for cancer therapy. In this study, we evaluated the effect of Ferula gummosa Boiss flower and leaf extracts on...

  • Quantitative Characterization of Cellular Membrane-Receptor Heterogeneity through Statistical and Computational Modeling. Weddell, Jared C.; Imoukhuede, P. I. // PLoS ONE;May2014, Vol. 9 Issue 5, p1 

    Cell population heterogeneity can affect cellular response and is a major factor in drug resistance. However, there are few techniques available to represent and explore how heterogeneity is linked to population response. Recent high-throughput genomic, proteomic, and cellomic approaches offer...

  • Carbohydrate-binding protein CLEC14A regulates VEGFR-2- and VEGFR-3-dependent signals during angiogenesis and lymphangiogenesis. Sungwoon Lee; Seung-Sik Rho; Hyojin Park; Jeong Ae Park; Jihye Kim; In-Kyu Lee; Gou Young Koh; Naoki Mochizuki; Young-Myeong Kim; Young-Guen Kwon; Lee, Sungwoon; Rho, Seung-Sik; Park, Hyojin; Park, Jeong Ae; Kim, Jihye; Lee, In-Kyu; Koh, Gou Young; Mochizuki, Naoki; Kim, Young-Myeong; Kwon, Young-Guen // Journal of Clinical Investigation;Feb2017, Vol. 127 Issue 2, p457 

    Controlled angiogenesis and lymphangiogenesis are essential for tissue development, function, and repair. However, aberrant neovascularization is an essential pathogenic mechanism in many human diseases, including diseases involving tumor growth and survival. Here, we have demonstrated that mice...

  • Hypoxia-induced expression of phosducin-like 3 regulates expression of VEGFR-2 and promotes angiogenesis. Srinivasan, Srimathi; Chitalia, Vipul; Meyer, Rosana; Hartsough, Edward; Mehta, Manisha; Harrold, Itrat; Anderson, Nicole; Feng, Hui; Smith, Lois; Jiang, Yan; Costello, Catherine; Rahimi, Nader // Angiogenesis;Oct2015, Vol. 18 Issue 4, p449 

    Expression and activation of vascular endothelial growth factor receptor 2 (VEGFR-2) by VEGF ligands are the main events in the stimulation of pathological angiogenesis. VEGFR-2 expression is generally low in the healthy adult blood vessels, but its expression is markedly increased in the...

  • Low Energy Shock Wave Therapy Induces Angiogenesis in Acute Hind-Limb Ischemia via VEGF Receptor 2 Phosphorylation. Holfeld, Johannes; Tepeköylü, Can; Blunder, Stefan; Lobenwein, Daniela; Kirchmair, Elke; Dietl, Marion; Kozaryn, Radoslaw; Lener, Daniela; Theurl, Markus; Paulus, Patrick; Kirchmair, Rudolf; Grimm, Michael // PLoS ONE;Aug2014, Vol. 9 Issue 8, p1 

    Objectives: Low energy shock waves have been shown to induce angiogenesis, improve left ventricular ejection fraction and decrease angina symptoms in patients suffering from chronic ischemic heart disease. Whether there is as well an effect in acute ischemia was not yet investigated. Methods:...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics